NCT03732560View on ClinicalTrials.gov

A Comparison of Nivolumab-based Treatments in a Real-world PD-L1 Positive Metastatic Melanoma Population in the US

CompletedOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

July 31, 2018

Primary Completion Date

March 25, 2021

Study Completion Date

March 25, 2021

Conditions
Melanoma
Interventions
OTHER

Non-Interventional

Non-Interventional

Trial Locations (1)

07054

Local Institution, Parsippany

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY